GoodRx Holdings Inc. (GDRX) shares are trading at lower $47.77 and the avg recommendation for the stock is Moderate Buy, while the current analyst price target stands at $58.69.
To add more color to this target, the company’s high over the last year is $64.22 and the low is $45.50 while the S&P 500 is up 14.27%. The catalyst for this interesting swing was the company’s recent earnings report.
A Notable Earnings Report
GDRX booked profit margins of 19.00%. All told, it is clear that, GDRX needs to be on your watchlist.
Find out when GDRX reaches critical levels. Subscribe to OracleDispatch.com Right Now by entering your Email in the box below.
Of course, we must look beyond the financials and question how well those numbers represent the sustainable earnings power of the business. Investors need to know how sustainable this current run. GDRX has a short ratio of 1.19 and outstanding shares of 391.74M.
GDRX has seen increased volume after this news and investors are putting their support behind the value proposition. Furthermore, 10-day volume stands at 1.25 million and more growth is possible in the weeks ahead. Traders will also note the company’s earnings per share came in at 0.23. Investors should also keep an eye on sector updates as GDRX has historically followed its peers on positive news.
All told, GoodRx Holdings Inc. GDRX has strung together solid data and demonstrated underlying fundamentals. At its current valuation, GDRX represents an interesting risk/reward case. Traders should stay tuned to see if this recent report will push the stock to test recent resistance levels.
GoodRx Holdings Inc. GDRX is now commanding a market cap of 18.71B and a float of 42.84M. GDRX is increasing its credibility in this sector and that could lead to more upside down the line. Sign-up for continuing coverage on shares of GDRX stock, as well as other hot stock picks, get our free newsletter today and get our next breakout pick!
Disclosure: we hold no position in GDRX, either long or short, and we have not been compensated for this article.